Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Amortization of Deferred Charges (2017 - 2024)

Mesa Laboratories' Amortization of Deferred Charges history spans 8 years, with the latest figure at $234000.0 for Q1 2024.

  • For Q1 2024, Amortization of Deferred Charges rose 2.63% year-over-year to $234000.0; the TTM value through Mar 2024 reached $926000.0, up 2.09%, while the annual FY2025 figure was $990000.0, 6.91% up from the prior year.
  • Amortization of Deferred Charges for Q1 2024 was $234000.0 at Mesa Laboratories, up from $231000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.4 million in Q1 2021 and bottomed at $221000.0 in Q2 2021.
  • The 5-year median for Amortization of Deferred Charges is $231000.0 (2023), against an average of $563000.0.
  • The largest annual shift saw Amortization of Deferred Charges rose 4.71% in 2020 before it tumbled 83.61% in 2022.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $1.4 million in 2020, then plummeted by 73.4% to $361000.0 in 2021, then plummeted by 37.12% to $227000.0 in 2022, then grew by 1.76% to $231000.0 in 2023, then rose by 1.3% to $234000.0 in 2024.
  • Per Business Quant, the three most recent readings for MLAB's Amortization of Deferred Charges are $234000.0 (Q1 2024), $231000.0 (Q4 2023), and $231000.0 (Q3 2023).